Answers are grounded in this paper and cite their sources.
Bullous pemphigoid (BP) is an autoimmune blistering disorder of the dermoepidermal junction, observed in individuals over the age of 70 years, and is conventionally managed with corticosteroids. In some cases, the traditional approach of medical management in combination with wound care is insufficient to resolve the persistent bullae and ulcers characteristic of the disease. We describe here the disease course, diagnosis, and treatment of a 57-year-old male with a four-year history of BP and treatment-resistant ulcers of the lower extremities. The wound addressed in this case was located on the distal anterior left lower extremity and further complicated by uncontrolled diabetes. The patient was managed in accordance with current guidelines under the care of a multidisciplinary team without resolution of the wound. Ultimately, success was found with a surgical approach using the dermal substitute, Integra® Bilayer Matrix Wound Dressing (Integra LifeSciences, Plainsboro, New Jersey).
No takes yet. Share an insight, caveat, or question.
Spongberg et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: